In a variable proportion of patients presenting with ST-segment elevation myocardial infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves …
T Svilaas, PJ Vlaar, IC van der Horst… - New England journal …, 2008 - Mass Medical Soc
Background Primary percutaneous coronary intervention (PCI) is effective in opening the infarct-related artery in patients with myocardial infarction with ST-segment elevation …
RP Betgem, GA De Waard, R Nijveldt… - Nature Reviews …, 2015 - nature.com
In patients with acute myocardial infarction (AMI), the guideline-recommended treatment is mechanical revascularization by percutaneous coronary intervention (PCI), which is effective …
JA Goldstein, B Maini, SR Dixon… - Circulation …, 2011 - Am Heart Assoc
Background—Percutaneous coronary intervention (PCI) is associated with periprocedural myocardial infarction (MI) in 3% to 15% of cases (depending on the definition used). In many …
BG Schwartz, RA Kloner - Journal of molecular and cellular cardiology, 2012 - Elsevier
The no-reflow phenomenon has been studied extensively in the basic science laboratory and has entered the clinical arena. No-reflow, which develops largely within the first 2h of …
G De Luca, EP Navarese, H Suryapranata - International journal of …, 2013 - Elsevier
INTRODUCTION: Even though primary angioplasty restores TIMI 3 flow in more than 90% of STEMI patients, the results in terms of myocardial perfusion are still unsatisfactory in a …
Background—Myocardial necrosis can occur during percutaneous coronary intervention (PCI) despite optimal adjunctive pharmacology and careful technique. We investigated the …
AO Chen, Z Chen, Y Zhou, Y Wu, Y Xia, D Lu… - Cell Death & …, 2021 - nature.com
Coronary microembolization (CME), a common reason for periprocedural myocardial infarction (PMI), bears very important prognostic implications. However, the molecular …